System for targeted delivery of therapeutic agents
5,503,627 A 4/1996 McKinnon etal. 6,399,754 B1 6/2002 C001< _ 5,512,600 A 4/1996
M1kose1a1. 6,403,779 B1 6/2002 Kawasakl et al. 5,514,378 A 5/1996 M1koseta1 …
M1kose1a1. 6,403,779 B1 6/2002 Kawasakl et al. 5,514,378 A 5/1996 M1koseta1 …
Vaccine nanotechnology
2008-11-17 Assigned to THE BRIGHAM AND WOMEN'S HOSPITAL, INC. reassignment
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. ASSIGNMENT OF ASSIGNORS …
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. ASSIGNMENT OF ASSIGNORS …
Vaccine nanotechnology
2013-03-26 Assigned to MASSACHUSETTS INSTITUTE OF TECHNOLOGY reassignment
MASSACHUSETTS INSTITUTE OF TECHNOLOGY ASSIGNMENT OF ASSIGNORS …
MASSACHUSETTS INSTITUTE OF TECHNOLOGY ASSIGNMENT OF ASSIGNORS …
Polymers for functional particles
The present invention generally relates to polymers and mac romolecules, in particular, to
block polymers useful in par ticles Such as nanoparticles. One aspect of the invention is …
block polymers useful in par ticles Such as nanoparticles. One aspect of the invention is …
Targeting of antigen presenting cells with immunonanotherapeutics
2010-07-19 Assigned to THE BRIGHAM AND WOMEN'S HOSPITAL, INC. reassignment
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. ASSIGNMENT OF ASSIGNORS …
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. ASSIGNMENT OF ASSIGNORS …
System for targeted delivery of therapeutic agents
The present invention provides a drug delivery system for targeted delivery of therapeutic
agent-containing particles to tissues, cells, and intracellular compartments. The invention …
agent-containing particles to tissues, cells, and intracellular compartments. The invention …
Adjuvant incorporation in immunonanotherapeutics
2010-01-12 Assigned to PRESIDENT AND FELLOWS OF HARVARD COLLEGE
reassignment PRESIDENT AND FELLOWS OF HARVARD COLLEGE ASSIGNMENT OF …
reassignment PRESIDENT AND FELLOWS OF HARVARD COLLEGE ASSIGNMENT OF …
Microfluidic synthesis of organic nanoparticles
5,174.930 A 12/1992 Stainmesse 6,095,148 A 8, 2000 Shastri et al. 5,175,296 A 12/1992
Gerster 6,107,094. A 8/2000 Crooke 5, 190,521. A 3/1993 Hubbard et al. 6,110,462 A …
Gerster 6,107,094. A 8/2000 Crooke 5, 190,521. A 3/1993 Hubbard et al. 6,110,462 A …
Polymer-encapsulated reverse micelles
A method for encapsulating nucleic acids, particularly siRNAs, shRNAs, microRNAs, gene
therapy plasmids, and other oligonucleotides in biodegradable polymers is disclosed …
therapy plasmids, and other oligonucleotides in biodegradable polymers is disclosed …
Adjuvant incorporation in immunoanotherapeutics
2013-12-31 Assigned to PRESIDENT AND FELLOWS OF HARVARD COLLEGE
reassignment PRESIDENT AND FELLOWS OF HARVARD COLLEGE ASSIGNMENT OF …
reassignment PRESIDENT AND FELLOWS OF HARVARD COLLEGE ASSIGNMENT OF …